Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 42

Trial Status

Completed2
Terminated1
Other2

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT05870462Phase 4Unknown
Semaglutide and Vascular Regeneration
AtherosclerosisCardiovascular DiseasesDiabetes Mellitus, Type 2+1 more
PrincipalinvestigatorStart date: 2023-04-29
NCT05271591Completed
Generalizability of REDUCE-IT Results to People of South Asian Descent With Atherosclerotic Cardiovascular Disease in Canada (REDUCE-IT Canada SA)
Atherosclerotic Cardiovascular DiseaseCardiovascular DiseasesCoronary Heart Disease+1 more
PrincipalinvestigatorStart date: 2022-03-05
NCT04562467Phase 4Completed
The Use of Icosapent Ethyl on Vascular Progenitor Cells in Individuals With Elevated Cardiovascular Risk
Cardiovascular DiseasesCardiovascular Risk FactorDiabetes Mellitus, Type 2+1 more
PrincipalinvestigatorStart date: 2020-09-24
NCT02793895Not ApplicableTerminated
Detection of Atrial Fibrillation After Cardiac Surgery
Arrhythmias, CardiacAtrial FibrillationAtrial Flutter+1 more
PrincipalinvestigatorStart date: 2017-02-24

Research Network

Collaboration Network

16 collaborators·20 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

David A Hess, PhD

Robarts Research Institute, London, Ontario

Very Similar
3 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Cardiovascular DiseasesAtherosclerosis+3 more

Worked with same sponsors:

Canadian Medical and Surgical Knowledge Translation Research GroupHLS Therapeutics, Inc+3 more
Collaborated on 3 trials
Similarity Score72%

David Mazer, MD

Unity Health Toronto

Similar
9 trials

Shared therapeutic areas:

AtherosclerosisCardiovascular DiseasesC.Surgical Procedure; Cardiac+2 more

Worked with same sponsors:

Canadian Medical and Surgical Knowledge Translation Research GroupUnity Health Toronto+1 more
Collaborated on 1 trial
Similarity Score54%

Andrew CT Ha, MD

University Health Network, Toronto

Moderately Similar
1 trials

Shared therapeutic areas:

Arrhythmias, CardiacAtrial FibrillationAtrial Flutter+1 more

Worked with same sponsors:

Unity Health Toronto
Collaborated on 1 trial
Similarity Score44%

Deepak L Bhatt, MD, MPH

Brigham and Women's Hospital, Boston, Massachusetts

Moderately Similar
1 trials

Shared therapeutic areas:

Cardiovascular DiseasesHeart Disease Risk FactorsDiabetes Mellitus, Type 2+1 more

Worked with same sponsors:

Canadian Medical and Surgical Knowledge Translation Research GroupHLS Therapeutics, Inc+2 more
Collaborated on 1 trial
Similarity Score44%

Hwee Teoh, PhD

Unity Health Toronto

Moderately Similar
1 trials

Shared therapeutic areas:

AtherosclerosisCardiovascular DiseasesDiabetes Mellitus, Type 2+1 more

Worked with same sponsors:

Canadian Medical and Surgical Knowledge Translation Research GroupUnity Health Toronto+1 more
Collaborated on 1 trial
Similarity Score44%

Atul Verma, MD

St. Michael's Hospital and Southlake Regional Health Centre

Moderately Similar
1 trials

Shared therapeutic areas:

Arrhythmias, CardiacAtrial FibrillationAtrial Flutter+1 more

Worked with same sponsors:

Unity Health Toronto
Collaborated on 1 trial
Similarity Score44%

Andrea Natale, MD

Texas Cardiac Arrhythmia Research Foundation

Related
18 trials

Shared therapeutic areas:

Atrial FibrillationArrhythmias, CardiacMyocardial Infarction+1 more
Similarity Score9%

Shirley Wang, PhD, ScM

Brigham and Women's Hospital

Related
51 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Atrial FibrillationObesity+1 more
Similarity Score9%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Obesity
Similarity Score5%

ali ismail, lecturer

Cairo University

Related
29 trials

Shared therapeutic areas:

ObesityDiabetes Mellitus, Type 2
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT05870462Phase 4PrincipalInvestigator

Semaglutide and Vascular Regeneration

AtherosclerosisCardiovascular DiseasesDiabetes Mellitus, Type 2+1 more
Unknown
NCT05271591PrincipalInvestigator

Generalizability of REDUCE-IT Results to People of South Asian Descent With Atherosclerotic Cardiovascular Disease in Canada (REDUCE-IT Canada SA)

Atherosclerotic Cardiovascular DiseaseCardiovascular DiseasesCoronary Heart Disease+1 more
Completed
NCT04562467Phase 4PrincipalInvestigator

The Use of Icosapent Ethyl on Vascular Progenitor Cells in Individuals With Elevated Cardiovascular Risk

Cardiovascular DiseasesCardiovascular Risk FactorDiabetes Mellitus, Type 2+1 more
Completed
NCT02793895Not ApplicablePrincipalInvestigator

Detection of Atrial Fibrillation After Cardiac Surgery

Arrhythmias, CardiacAtrial FibrillationAtrial Flutter+1 more
Terminated
NCT06108388PrincipalInvestigator

Functional Investigation of Endothelial Function and Regenerative Cell Exhaustion

Diabetes Mellitus, Type 2
Unknown

All 5 trials loaded